Allspring Global Investments
TEVA icon

Allspring Global Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Allspring Global Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.8M Sell
1,458,911
-205,635
-12% -$6.85M 0.07% 307
2026
Q1 		$50.4M Sell
1,664,546
-159,581
-9% -$5.13M 0.08% 282
2025
Q4 		$56.5M Sell
1,824,127
-114,603
-6% -$2.82M 0.09% 251
2025
Q3 		$38.9M Sell
1,938,730
-4,028,774
-68% -$70.8M 0.06% 363
2025
Q2 		$99.3M Sell
5,967,504
-316,184
-5% -$5.1M 0.17% 151
2025
Q1 		$96.1M Buy
6,283,688
+5,186,592
+473% +$92.6M 0.17% 144
2024
Q4 		$23.4M Buy
1,097,096
+1,045,305
+2,018% +$19M 0.04% 490
2024
Q3 		$933K Sell
51,791
-10,619
-17% -$186K ﹤0.01% 1348
2024
Q2 		$1.01M Buy
62,410
+25,657
+70% +$395K ﹤0.01% 1335
2024
Q1 		$519K Buy
36,753
+7,763
+27% +$97.9K ﹤0.01% 1522
2023
Q4 		$303K Buy
28,990
+12,882
+80% +$120K ﹤0.01% 1606
2023
Q3 		$164K Buy
+16,108
New +$150K ﹤0.01% 1817

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Allspring Global Investments's TEVA Position: Q2 2026 in Review

Allspring Global Investments reduced its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, selling an estimated $6.85M and leaving 1,458,911 shares worth $48.8M. The position accounts for 0.07% of the portfolio, ranked #307.

Allspring Global Investments first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $99.3M in Q2 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Allspring Global Investments held 1,458,911 shares of Teva Pharmaceuticals worth $48.8M as of Q2 2026.
  • Allspring Global Investments sold 205,635 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.85M.
  • Teva Pharmaceuticals made up 0.07% of Allspring Global Investments's portfolio in Q2 2026, its #307 holding.
  • Allspring Global Investments first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Allspring Global Investments's Teva Pharmaceuticals position peaked at $99.3M in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.